Atlas Trials

Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

Clinical trial NCT04485325 · COMPLETED

Trial details

NCT number
NCT04485325
Sponsor
Dr. Frank Behrens
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatic Arthritis
Start date
2019-11-04
Primary completion
2024-03-31
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.